Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

Descripción completa

Detalles Bibliográficos

Autores principales:	Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	SpringerOpen 2024-11-01
Colección:	Future Journal of Pharmaceutical Sciences
Materias:	Metformin hydrochloride Teneligliptin hydrobromide hydrate Pioglitazone hydrochloride Analytical quality by design Response surface modeling
Acceso en línea:	https://doi.org/10.1186/s43094-024-00746-7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!